Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate WP_013553296.1 NITSA_RS01685 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::A6TL04 (425 letters) >NCBI__GCF_000186245.1:WP_013553296.1 Length = 430 Score = 309 bits (792), Expect = 9e-89 Identities = 190/412 (46%), Positives = 251/412 (60%), Gaps = 14/412 (3%) Query: 15 TVPGDKSISHRAIMLSSISKGTSRVKGFLRGEDCLSTISCFRDLGIDIED--RGTEIIIQ 72 T+ DKSISHR M S S S V+ FL+GED L+++S R LG ++E+ GT I Sbjct: 19 TIAPDKSISHRCAMFSLFSDRPSTVRNFLKGEDTLASLSIARQLGAEVEEDEAGTLRITP 78 Query: 73 GKGLHGLSEPLNVLDAGNSGTTIRLISGILAGQKFLTIVTGDASLRKRPMERIATPLRKM 132 L EP ++LD GN+GT +RL G+LAG + ++TGD LR RPM+R+ PL+ + Sbjct: 79 PVELR---EPDDILDCGNAGTGMRLYCGLLAGVEGSFVLTGDRYLRSRPMKRVTGPLQSI 135 Query: 133 GAFIEGRDYGNLAPLVIRGGNLKGMDYASPVSSAQVKSAILLAGLYGEGDTIVREKITSR 192 GA I+GR+ GNLAPL IRGG LK Y SP+ SAQVKSA++LA L G+ + RE SR Sbjct: 136 GAKIDGREEGNLAPLHIRGGKLKAFRYESPIDSAQVKSAMILAALRGDAPSYYRENFLSR 195 Query: 193 DHTEKMLKGLGANISTDQG---VTRLGKSELYGQSIEVPGDISSAAFFMAGAAALPGSFL 249 DHTE+ML+G+GA+I TD V + L I VP D SSA FF AA +PG+ + Sbjct: 196 DHTERMLRGMGASIETDAEGWIVVKPLTKPLNPLDITVPADPSSAFFFAVAAAIVPGAKV 255 Query: 250 ITEGVGLNPTRTGIIDVLRDMGGDIEIHNLRQSGGEEIGDIMIR-GKKLYGTEIGKEIIP 308 GV LNPTR VL MG +E + LR+ E IG+I + +L E+ I Sbjct: 256 RIPGVTLNPTRIEAYKVLEAMGAAVE-YALREDRYEPIGEIRVAYDGRLSAVEVSHR-IA 313 Query: 309 RLIDEIPVLAIIAATAEGKTIITGAEELKVKESNRITAMVTEMQKVGIKVTELPDGMEIE 368 LIDE+P LA+ ATAEG + + A EL+VKES+RI +VT ++ GI+ E PDG I Sbjct: 314 WLIDELPALAVAMATAEGVSRVRNAAELRVKESDRIATVVTALKACGIEAEEYPDGYAIR 373 Query: 369 GGQVITGGRVESYGDHRIAMAMAICGLFAQEPIKINDSQCIDISFPNFEEKL 420 GG + ++S+GDHRIAM+ AI GL ++I D C+ SFPNF E L Sbjct: 374 GG-TLRRAVIDSHGDHRIAMSFAIAGLLC--GMEIEDIDCVATSFPNFFEIL 422 Lambda K H 0.317 0.138 0.383 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 490 Number of extensions: 27 Number of successful extensions: 7 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 425 Length of database: 430 Length adjustment: 32 Effective length of query: 393 Effective length of database: 398 Effective search space: 156414 Effective search space used: 156414 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.6 bits) S2: 51 (24.3 bits)
Align candidate WP_013553296.1 NITSA_RS01685 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.21306.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 1.3e-125 405.4 0.0 1.6e-125 405.1 0.0 1.0 1 lcl|NCBI__GCF_000186245.1:WP_013553296.1 NITSA_RS01685 3-phosphoshikimate Domain annotation for each sequence (and alignments): >> lcl|NCBI__GCF_000186245.1:WP_013553296.1 NITSA_RS01685 3-phosphoshikimate 1-carboxyvinyltransferase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 405.1 0.0 1.6e-125 1.6e-125 4 413 .. 19 426 .. 18 428 .. 0.96 Alignments for each domain: == domain 1 score: 405.1 bits; conditional E-value: 1.6e-125 TIGR01356 4 kipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakve.eekeelviegvgglkepea 71 +i+++KSishR +++++++ +++v+n+Lk+eDtla+l++ r+lGa+ve +e ++l i++ l+ep++ lcl|NCBI__GCF_000186245.1:WP_013553296.1 19 TIAPDKSISHRCAMFSLFSDRPSTVRNFLKGEDTLASLSIARQLGAEVEeDEAGTLRITPPVELREPDD 87 589**********************************************5559*******999****** PP TIGR01356 72 eldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlaisgpl 140 +ld+gn+Gt +Rl+ g+la ++g++vltgd l+ RP++r++ +L+++ga+i+ +ee + +Pl+i+g++ lcl|NCBI__GCF_000186245.1:WP_013553296.1 88 ILDCGNAGTGMRLYCGLLAGVEGSFVLTGDRYLRSRPMKRVTGPLQSIGAKIDGREEGNLAPLHIRGGK 156 *******************************************************************98 PP TIGR01356 141 kggivelsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeederkivv 209 + + s+ S+Q+ksa++laa l+++ + + e+ +sr+++e++L +++ +e + e ivv lcl|NCBI__GCF_000186245.1:WP_013553296.1 157 LKAFRYESPIDSAQVKSAMILAA---LRGDAPSYYRENFLSRDHTERMLRGMGAS---IETDAEGWIVV 219 88*********************...8899999*******************988...77777778999 PP TIGR01356 210 kggqkykqk.evevegDaSsAafflaaaaitge.evtvenlgenstqgdkaiiivLeemGadveveeqr 276 k+ k ++ +++v++D+SsA+ff++aaai ++ +v++ +++ n+t+ + + vLe+mGa ve++ + lcl|NCBI__GCF_000186245.1:WP_013553296.1 220 KPLTKPLNPlDITVPADPSSAFFFAVAAAIVPGaKVRIPGVTLNPTRIE--AYKVLEAMGAAVEYALRE 286 9999955555***************************************..555***********9888 PP TIGR01356 277 .......dvevegasklkgvkvdidvdsliDelptlavlaafAegetriknieelRvkEsdRiaaiaee 338 +++v l++v+v ++++ liDelp+lav++a Aeg++r++n++elRvkEsdRia ++++ lcl|NCBI__GCF_000186245.1:WP_013553296.1 287 dryepigEIRVAYDGRLSAVEVSHRIAWLIDELPALAVAMATAEGVSRVRNAAELRVKESDRIATVVTA 355 88***********99****************************************************** PP TIGR01356 339 LeklGveveeledgllieGkkkelkgavvdtydDHRiamalavlglaaegeveiedaecvaksfPeFfe 407 L++ G+e+ee +dg i+G+ +l+ av+d+++DHRiam++a++gl + +eied cva+sfP+Ffe lcl|NCBI__GCF_000186245.1:WP_013553296.1 356 LKACGIEAEEYPDGYAIRGG--TLRRAVIDSHGDHRIAMSFAIAGLLCG--MEIEDIDCVATSFPNFFE 420 ********************..6*************************6..****************** PP TIGR01356 408 vleqlg 413 l +l+ lcl|NCBI__GCF_000186245.1:WP_013553296.1 421 ILSNLT 426 **9986 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (430 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 10.94 // [ok]
This GapMind analysis is from Apr 10 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory